Cancer and malaria researchers from the University of Copenhagen (UCPH) and the University of British Columbia (UBC) discovered that malaria proteins armed with a toxin can kill cancer, according to a report by UCPH.
Mads Daugaard from the University of British Columbia and malaria researcher Ali Salanti from UCPH revealed that the carbohydrate that the malaria parasite attaches itself to in the placenta in pregnant women is identical to a carbohydrate found in cancer cells.
In the laboratory, scientists added a toxin to the protein that the malaria parasite uses to adhere to the placenta. This combination of malaria protein and toxin seeks out the cancer cells, is absorbed, the toxin is released inside, and then the cancer cells die, according to the UCPH report.
Using cell cultures and mice with cancer, the researchers tested thousands of samples from brain tumors to leukemias and found the malaria protein is able to attack more than 90% of all types of tumors.
With non-Hodgkin’s lymphoma, the treated mice’s tumors were about a quarter the size of the tumors in the control group. With prostate cancer, the tumors disappeared in two of the six treated mice a month after receiving the first dose. With metastatic bone cancer, five out of six of the treated mice were alive after almost eight weeks, compared to none of the mice in a control group.
The discovery was described in a recent article in the renowned scientific journal Cancer Cell.
Photo captions:1) Cancer cell 2) Cancer researcher Mads Daugaard.
About the writer: Mark Ellis is senior correspondent for the ASSIST News service and also the founder of www.Godreports.com , a website that shares stories, testimonies and videos from the church aorund the world to build interest and involvement in world missions.
** You may republish this or any of our ANS stories with attribution to the ASSIST News Service (www.assistnews.net)